Dutch pension fund dumps Mylan on worries about death penalty drug

Europeans have had a bone to pick with companies supplying death penalty drugs to U.S. prisons, with government officials restricting exports and prompting shortages. In the latest chapter of the saga, a Dutch pension fund is selling out of Mylan ($MYL) after discovering that one of its products is stocked at a U.S. prison that carries out executions. More from FiercePharma